Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.
Guardant Health has raised $350.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in November 2025.
Guardant Health's investors include Temasek, Lightspeed Venture Partners, Plug and Play, Sequoia Capital, Khosla Ventures.
Guardant Health is headquartered in Redwood City, United States.
Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.
Guardant Health is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Guardant Health — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/guardant-health. Accessed July 18, 2026.
VCBacked. (2025). Guardant Health — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/guardant-health
{{cite web |title=Guardant Health — Funding & Investors |url=https://www.vcbacked.co/company/guardant-health |website=VCBacked |access-date=July 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated